The interim analysis suggests that looking at platelet reactivity units and high on-treatment platelet reactivity; there may be a positive trend for better efficacy for those treated with the ticagrelor and aspirin combination.
← all excerpts
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin.
1
—
—